PLATINUM-RESISTANT OVARIAN HIGH GRADE SEROUS ADENOCARCINOMA

Clinical trials for PLATINUM-RESISTANT OVARIAN HIGH GRADE SEROUS ADENOCARCINOMA explained in plain language.

Never miss a new study

Get alerted when new PLATINUM-RESISTANT OVARIAN HIGH GRADE SEROUS ADENOCARCINOMA trials appear

Sign up with your email to follow new studies for PLATINUM-RESISTANT OVARIAN HIGH GRADE SEROUS ADENOCARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

Scientists test new drug duo to attack tough cancers

Disease control Recruiting now

This early-stage study is testing a new combination of two drugs, DS-8201a and olaparib, for people with advanced cancers that have a protein called HER2. The main goal is to find the safest and most effective dose. Researchers will also check if the treatment helps shrink or con…

Matched conditions: PLATINUM-RESISTANT OVARIAN HIGH GRADE SEROUS ADENOCARCINOMA

Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control

Last updated Mar 30, 2026 14:31 UTC

PLATINUM-RESISTANT OVARIAN HIGH GRADE SEROUS ADENOCARCINOMA

Get alerted when new PLATINUM-RESISTANT OVARIAN HIGH GRADE SEROUS ADENOCARCINOMA trials appear

Scientists test new drug duo to attack tough cancers